Loading clinical trials...

Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT00547560

Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population

To assess the safety and tolerability of ascending, multiple, oral doses of GSI-953 in healthy elderly subjects.

Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Collaborators

Pfizer

Related studies

Cytapheresis of Volunteer Donors

NCT00104325 · Healthy Volunteers

RECRUITINGPhase 1

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

NCT07470866 · Healthy

RECRUITINGPhase 1

A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

NCT06637865 · Healthy

RECRUITINGPhase 1

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

NCT07388667 · Healthy

Sodium vs Potassium Education to Improve Vascular Health

NCT07221448 · Healthy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 4, 2011Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment49

Start dateAug 2007

Last updatedApr 4, 2011

Condition

Locations shown

Pfizer Investigational Site

Miami, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 4, 2011Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions